תבנית:תרופה/אפורציו IU 2000 - Eporatio 2000 iu

×©××× ××Â !
××ª×¨××¤× × ×¢××× ×:××××¨ ××ª×¨××¤××ª ×©× ××©×¨× ×××¨××××ª.
×× ××ª×§××× ××××¢× ×¢× ××¤×¡×§×ª ×©××××§ ××ª×¨××¤× ×:××¢×¨××ª ×××××¢××ª ×¢× ××¤×¡×§×ª ×©××××§ ×ª×¨××¤××ª.
×ª××¨×× ×¢×××× ×××¨×× ××ª×¨××¤× ×× ××××§××ª×¨××¤××ª ××× 14/02/18.

× ×ª×× × ×ª×¨××¤×

××¡× ×××¨××××ª

×××¨×©×

××× ×× ×× × ××¡×¤××	××¤××¨×¦×× IU 10,000 - Eporatio 10,000 iu ××¤××¨×¦×× IU 1000 - Eporatio 1000 iu ××¤××¨×¦×× IU 20,000 - Eporatio 20,000 iu ××¤××¨×¦×× IU 30,000 - Eporatio 30,000 iu ××¤××¨×¦×× IU 3000 - Eporatio 3000 iu ××¤××¨×¦×× IU 4000 - Eporatio 4000 iu ××¤××¨×¦×× IU 5000 - Eporatio 5000 iu
×§×××¦× ×¤×¨××§××××××ª (ATC4)	B03XA Other antianemic preparations
××¨××× ×¤×¢×× (ATC5)	Â Epoetin theta (r-huepo) 2000 IU / 0.5 ML âB03XA01
×¦××¨×ª ××ª×	×ª×ª-×¢××¨×, ×ª××-××¨××× - S.C, I.V
×¦××¨×ª ××× ××	×ª×××¡× ××××¨×§×, SOLUTION FOR INJECTION ××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××
××ª××××	- Treatment of symptomatic anaemia associated with chronic renal failure in adult patients.- Treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
×ª×× ××ª:× ×ª×× × ×¡×/×ª×¨××¤×/××¤××¨×¦×× IU 2000 - Eporatio 2000 iu
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	××× ×¢××× ××¨××¤× Â

×¢××× ××¦×¨××	Â

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
[ ××¤××¨×¦×× IU 2000] ×××××¨ ××©×¨× ×××¨××××ª

××£ ×× × ××¦×¨ ×¢× ××× ××× ××××××¨ ×ª×× ××ª ×¢× ×¤×¨×× ××ª×¨××¤×.

{{×ª×¨××¤×/××¤××¨×¦×× IU 2000 - Eporatio 2000 iu}}

×:

{{×ª×¨××¤×/××¤××¨×¦×× IU 2000 - Eporatio 2000 iu
| ×©× ××¤×¨×××¨=×¢×¨× ×××© (×××¨×¡ ××ª ××¢×¨× ×©×××× ×××××¨)
}}

השינוי האחרון נעשה בֹ־27 בפברואר 2024 ב־16:19

ויקיתרופות